Paige Mahaney insider trades
Open-market stock purchases and sales by Paige Mahaney, Chief Scientific Officer at C4 Therapeutics, Inc, from SEC Form 4 filings since Oct 28, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc | Sold (not open market) | $4.6K |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |
| Oct 28, 2025 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |
| Oct 28, 2025 | CCCC C4 Therapeutics, Inc | Sold (not open market) | $14.6K |
Companies traded
- CCCC C4 Therapeutics, Inc: other filings, last Feb 14, 2026